Gerhard Braun

Gerhard Braun is an experienced professional in the pharmaceutical industry, currently serving as the Head of Small Molecule Development Services and Small- / Mid-Scale Operations at Lonza since August 2023. Prior to this role, Gerhard spent over 14 years at Bayer Pharmaceuticals, holding positions such as Head of Manufacturing Science & Technology and Head of Process Research and Development, where responsibilities included driving manufacturing strategies and leading teams focused on chemical synthesis and process development. Gerhard's earlier career at Bayer encompassed roles in innovation management, lab leadership, and plant management, all contributing to significant advancements in Active Pharmaceutical Ingredients. Gerhard holds a PhD in Chemistry from both the Max-Planck Institute für Kohleforschung and RWTH Aachen University, along with a Diplom and Pre-diploma in Chemistry from the University of Cologne and The University of Freiburg, respectively.